HeartBeam Launches IPO With 12.5M Shares

HeartBeam has completed the acquisition of HeartBeam, a medical devices business in the healthcare sector in the United States, for $10 million. HeartBeam develops cardiology-focused medical devices and supports commercialization efforts for cardiac care technologies. The company’s underwritten public offering priced 12.5 million shares to fund growth initiatives tied to cardiology product adoption. The deal is categorized as other acquisition, with gross proceeds of $10 million before underwriting discounts, commissions, and offering expenses, and it is currently announced.